Top Markets
Coin of the day
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Peringkat dalam Saham #25243
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Harga Saham
$23.57
Terakhir disinkronkan: 2026-08-20
Kapitalisasi Pasar
$51.76M
Perubahan (1 hari)
-0.08%
Perubahan (1 tahun)
289.59%
Negara
US
Perdagangan Apollomics, Inc. (APLM)

Kategori

Riwayat harga saham Apollomics, Inc. (APLM)
Harga penutupan tertinggi: $20.22 pada 2026-08-01

Harga penutupan terendah: $990.67 pada 2021-11-01
Riwayat harga saham Apollomics, Inc. dari 2021 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 0.80%
2025 83.86%
2024 -88.89%
2023 -91.94%
2022 3.60%
2021 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$761.87 8.65%
CH
$130.43 397.46%
US